IRIS
ODDO, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.685
AS - Asia 1.401
EU - Europa 1.242
SA - Sud America 520
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 4.904
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.637
SG - Singapore 744
IE - Irlanda 496
BR - Brasile 459
SE - Svezia 295
HK - Hong Kong 287
CN - Cina 158
IT - Italia 152
DE - Germania 73
IN - India 63
VN - Vietnam 45
FR - Francia 32
NL - Olanda 32
GB - Regno Unito 30
AR - Argentina 25
CA - Canada 25
FI - Finlandia 25
RU - Federazione Russa 22
AT - Austria 21
ZA - Sudafrica 20
PL - Polonia 16
JP - Giappone 15
BD - Bangladesh 12
MX - Messico 11
UA - Ucraina 11
ES - Italia 9
EU - Europa 9
TR - Turchia 9
EC - Ecuador 8
AU - Australia 7
CZ - Repubblica Ceca 7
PY - Paraguay 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
IQ - Iraq 6
LT - Lituania 6
MY - Malesia 6
CO - Colombia 5
ID - Indonesia 5
TN - Tunisia 5
UZ - Uzbekistan 5
CL - Cile 4
JO - Giordania 4
MA - Marocco 4
PK - Pakistan 4
TW - Taiwan 4
IL - Israele 3
KZ - Kazakistan 3
LK - Sri Lanka 3
PE - Perù 3
SA - Arabia Saudita 3
TH - Thailandia 3
AZ - Azerbaigian 2
BE - Belgio 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KE - Kenya 2
KR - Corea 2
KW - Kuwait 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
GE - Georgia 1
GN - Guinea 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.904
Salva come PNG Salva come JPEG
Città #
Dublin 496
Singapore 384
Hong Kong 286
Nyköping 277
Ashburn 272
Dallas 253
Chandler 86
Princeton 86
Medford 85
Los Angeles 83
Des Moines 64
Messina 54
Pune 46
The Dalles 42
Redondo Beach 39
Beijing 37
Buffalo 37
Council Bluffs 37
São Paulo 34
Munich 29
Brooklyn 28
Rio de Janeiro 22
Tianjin 22
Boardman 20
Ho Chi Minh City 20
New York 19
Nuremberg 18
Tokyo 14
Wilmington 14
Johannesburg 12
Turku 12
Vienna 12
Warsaw 12
Montreal 11
San Francisco 11
Atlanta 10
Hanoi 10
Phoenix 10
Amsterdam 9
Frankfurt am Main 9
Orem 9
Porto Alegre 9
Stockholm 9
Belo Horizonte 8
Catania 8
Düsseldorf 8
Jiaxing 8
Rome 8
Santa Clara 8
Brno 7
Chennai 7
Denver 7
Guarulhos 7
Jinan 7
Palermo 7
Boston 6
Campinas 6
Charlotte 6
Chicago 6
London 6
Ningbo 6
Toronto 6
Goiânia 5
Helsinki 5
Lappeenranta 5
Manchester 5
Norwalk 5
Poplar 5
Recife 5
São Bernardo do Campo 5
Amman 4
Araras 4
Augusta 4
Baghdad 4
Bexley 4
Curitiba 4
Dhaka 4
Hyderabad 4
Joinville 4
Lauterbourg 4
Manaus 4
Mexico City 4
Nova Iguaçu 4
Salvador 4
Taizhou 4
Tashkent 4
Wroclaw 4
Ankara 3
Belford Roxo 3
Bismarck 3
Bogotá 3
Brasília 3
Cairo 3
Campina Grande 3
Cape Town 3
Catanduva 3
Caxias do Sul 3
Fortaleza 3
Indaiatuba 3
Istanbul 3
Totale 3.328
Salva come PNG Salva come JPEG
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 276
A Novel Serum-Based Diagnosis of Alzheimer's Disease Using an Advanced Phage-Based Biochip 124
Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders 101
ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD 86
BACE1 Elevation is Involved in Amyloid Plaque Development in the Triple Transgenic Model of Alzheimer‘s Disease: Differential Aβ Antibody Labeling of Early-Onset Axon Terminal Pathology 85
Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders 81
Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aß oligomers accumulation 80
Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice 79
Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice 77
Multipotential Role of Growth Factor Mimetic Peptides for Osteochondral Tissue Engineering 75
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer‘s disease 75
Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer's disease 73
Alzheimer's disease: Abeta, tau and synaptic dysfunction 71
Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome 71
Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease 67
Administration of a selective beta 2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease 66
Autophagic/lysosomal dysfunction in Alzheimer's disease 65
Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology 64
Physiologic Response Evaluation of Human Foetal Osteoblast Cells within Engineered 3D-Printed Polylactic Acid Scaffolds 63
Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits 63
The ubiquitin-proteasome system in Alzheimer‘s disease 60
Generation of a Biotin-Tagged Dual-Display Phage 59
Amyloid deposits show complexity and intimate spatial relationship with dendrosomatic plasma membranes: an electron microscopic 3D reconstruction analysis in 3xTg-AD mice and aged canine 59
An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer's Disease 58
A dynamic relationship between intracellular and extracellular pools of Abeta 58
The Role of the Transcription Factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities 57
Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer‘s disease 56
Maternal choline supplementation ameliorates Alzheimer's disease pathology by reducing brain homocysteine levels across multiple generations 56
Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification 55
Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology 53
Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation? 51
Necroptosis activation in Alzheimer's disease 50
Experience-dependent regulation of vesicular zinc in male and female 3xTg-AD mice 49
Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer‘s disease 49
Intracellular amyloid-beta in Alzheimer‘s disease 48
beta(2) Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models 48
Silicon‐Based Sensing Surface for Alzheimer's Disease Diagnosis by Phages Probes 48
Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles 47
Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles 47
Increased intraneuronal resting [Ca2+] in adult Alzheimer‘s disease mice 46
Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease 45
Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits 45
M1 receptors play a central role in modulating AD-like pathology in transgenic mice 44
Genetic suppression of beta 2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies 44
Congo red and thioflavin-T analogs detect Abeta oligomers 43
Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle 43
Triple-transgenic model of Alzheimer‘s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction 43
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer‘s disease 43
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice 42
mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease 42
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology 42
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease 41
Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice 41
Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice 41
The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease 40
Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice 40
Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia 40
Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature 40
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study 39
Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer‘s disease mice 39
Inhibition of soluble TNF signaling in a mouse model of Alzheimer‘s disease prevents pre-plaque amyloid-associated neuropathology 39
Oxidative Damage and Amyloid-beta Metabolism in Brain Regions of the Longest-Lived Rodents 39
Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer‘s disease 39
Glucocorticoids Exacerbate Cognitive Deficits in TDP-25 Transgenic Mice via a Glutathione-Mediated Mechanism: Implications for Aging, Stress and TDP-43 Proteinopathies 39
Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice 38
Modeling behavioral and neuronal symptoms of Alzheimer‘s disease in mice: a role for intraneuronal amyloid 38
Generation of a helper phage for the fluorescent detection of peptide-target interactions by dual-display phages 37
Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology 37
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer‘s disease progression 37
Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism 37
Identification of learning-induced changes in protein networks in the hippocampi of a mouse model of Alzheimer's disease 37
Toxic role of K+ channel oxidation in mammalian brain 36
Neural stem cells improve memory in an inducible mouse model of neuronal loss 36
The role of nicotinic acetylcholine receptors in Alzheimer‘s disease 35
Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43 35
Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability 35
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story 35
Intraneuronal Abeta causes the onset of early Alzheimer‘s disease-related cognitive deficits in transgenic mice 35
Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease 35
Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease 34
Validation of a 2-day water maze protocol in mice 34
Life-long rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and NMDA signaling 34
Peripherally expressed neprilysin reduces brain amyloid burden: A novel approach for treating Alzheimer‘s disease 34
Dyrk1 inhibition improves Alzheimer's disease-like pathology 34
Methylene blue reduces Aβ levels and rescues early cognitive deficit by increasing proteasome activity 33
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer‘s disease 33
Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice 33
Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments 32
Genetically altering Abeta distribution from the brain to the vasculature ameliorates tau pathology 32
The Collagen Chaperone HSP47 Is a New Interactor of APP that Affects the Levels of Extracellular Beta-Amyloid Peptides 32
Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer‘s mouse models 32
Innovative Silicon-Based Sensing Strategy for the Alzheimer’s Disease Detection by Phage Display 31
Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease 31
CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer‘s disease 31
Sortilin is required for toxic action of Aβ oligomers (AβOs): Extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathways 31
Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease 30
The role of mTOR signaling in Alzheimer disease 30
Cognitive decline typical of FTLD in transgenic mice expressing the 25-kDa C-terminal fragment of TDP-43 28
mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies 27
Paving the Way for New Clinical Trials for Alzheimer's Disease 27
Totale 4.995
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.748
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202192 0 0 0 0 0 0 0 0 0 0 92 0
2021/2022326 9 0 0 1 5 4 41 22 5 0 3 236
2022/20231.021 107 67 48 22 36 100 21 47 544 4 20 5
2023/2024388 5 26 13 103 9 57 0 10 22 22 27 94
2024/20251.695 12 26 29 40 188 32 68 155 537 107 192 309
2025/20261.515 251 271 287 291 385 30 0 0 0 0 0 0
Totale 5.037